Kate Groot
-
- Growth Hormone and Insulin-like Growth Factors 76
- Pituitary Gland Disorders and Treatments 18
- Reproductive Medicine top 1%
- Hypothalamic control of reproductive hormones 20
- Oncology top 2%
- Peptidase Inhibition and Analysis 12
-
- Neuropeptides and Animal Physiology 23
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 14
-
- Neuroendocrine Tumor Research Advances 29
-
- Estrogen and related hormone effects 15
- Co-authors
- Andrew V. SchallyKároly SzepesháziGábor HalmosPatricia ArmatisGyörgy B. HalmosJózsef L. VargaJ. PinskiA. Jungwirth
- Journals
- Proceedings of the National Academy of Sciences (28 papers)The Prostate (11 papers)International Journal of Cancer (9 papers)
- Partner nations
- United StatesHungaryIndia
In The Last Decade
Kate Groot
143 papers receiving 4.8k citations
Peers
Comparison fields: 5 of 108
- Endocrinology, Diabetes and Metabolism 2.3k
- Reproductive Medicine 719
- Oncology 1.4k
- Cellular and Molecular Neuroscience 780
- Cancer Research 523
Countries citing papers authored by Kate Groot
This map shows the geographic impact of Kate Groot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kate Groot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kate Groot more than expected).
Fields of papers citing papers by Kate Groot
This network shows the impact of papers produced by Kate Groot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kate Groot. The network helps show where Kate Groot may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kate Groot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2003 | 11 | |
| 3 | 2003 | 49 | |
| 4 | 2000 | 21 | |
| 5 | 2000 | 53 | |
| 6 | 1999 | 39 | |
| 7 | GRHきっ坑薬のMZ‐5‐156は,ヌードマウスのDU‐145ヒトアンドロゲン非依存性前立腺癌の成長を阻害し,腫よう内のIGF2のレベル及びmRNA発現を低下させる | 1998 | 50 |
| 8 | 1998 | 27 | |
| 9 | 1997 | 76 | |
| 10 | 1996 | 60 | |
| 11 | 1996 | 10 | |
| 12 | 1996 | 4 | |
| 13 | 1995 | 9 | |
| 14 | 1995 | 84 | |
| 15 | Antitumor effects of analogs of somatostatin and antagonists of bombesin/GRP in experimental models of pancreatic cancer | 1994 | 3 |
| 16 | 1993 | 12 | |
| 17 | 1993 | 20 | |
| 18 | 1992 | 27 | |
| 19 | 1990 | 39 | |
| 20 | Suppression of testicular activity by a GnRH agonist in hypophysectomized, gonadotropin-treated mice. | 1989 | 2 |
About Kate Groot
Kate Groot is a scholar working on Endocrinology, Diabetes and Metabolism, Reproductive Medicine and Cellular and Molecular Neuroscience, having authored 143 papers that have together received 4.9k indexed citations. Recurring topics across this work include Growth Hormone and Insulin-like Growth Factors (76 papers), Neuroendocrine Tumor Research Advances (29 papers), Neuropeptides and Animal Physiology (23 papers), Hypothalamic control of reproductive hormones (20 papers), Pituitary Gland Disorders and Treatments (18 papers), Estrogen and related hormone effects (15 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Peptidase Inhibition and Analysis (12 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.3k citations), Reproductive Medicine (719 citations) and Oncology (1.4k citations). Kate Groot has collaborated with scholars based in United States, Hungary and India. Frequent co-authors include Andrew V. Schally, Károly Szepesházi, Gábor Halmos, Patricia Armatis, György B. Halmos, József L. Varga, J. Pinski, A. Jungwirth, Attila Nagy and Judit Horváth. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Prostate, International Journal of Cancer, Endocrinology and Peptides.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.